We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
Public debate has been riddled with confusing claims, technical incompetence and vested interests
Scientists are trying to understand the cause of neurological effects and whether symptoms will be long-lasting
Underfunding of some services and pent-up demand caused by lockdowns means some young people are waiting months for help
The creeping Americanisation of British medical bills reflects the strains on the NHS
Private equity giant teams up with India’s largest company in attempt to buy UK pharmacy chain
The final instalment of our series on innovation in European healthcare examines the effects of the slump in biotech valuations and changes in EU health policy
‘There has been a change in attitudes. There are a lot of initiatives that were not foreseen a couple of years ago’
‘Intricate dance’ under way to ensure simplified assessments of new medicines maintain quality and integrity
Biden’s flagship scheme giving antiviral pills to at-risk patients has run into multiple problems
Minority shareholders should push for a higher price as earnings are ripe for recovery
US private equity firm consortium makes leveraged buyout offer for Ramsay Health Care
Health service in England is grappling with twin challenges of Covid and clearing record treatment backlog
Sierra’s bone marrow cancer treatment had positive clinical trial results in January
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
Move could boost global development of drugs to ease antimicrobial resistance
Growing private equity investment in the health industry risks making the rich richer and the sick sicker
Ambulance and emergency care providers scale back services as cases of Omicron sub-variant continue to rise
Surprise approach for social care provider promises to relieve shareholders of stress
UK public service broadcaster swaps advertising slots for equity in medical marijuana group Cannaray
Responsibility for tackling conditions that affect life expectancy should not be left to government, study warns
UK trust has improved outcomes with innovative practice and long-term planning
12 mothers also died at Shrewsbury and Telford trust with many receiving treatment that ‘could have been significantly improved’
Dissatisfaction rises during the pandemic driven by concerns over waiting times, staff shortages and lack of funding
Belgravia hospital aims to partner with the NHS to cut waiting lists and help with the UK’s post-Covid recovery plan
UAE company collapsed after racking up $4bn of debts in an alleged fraud
International Edition
